Lisata Therapeutics, Inc. (LSTA)

NASDAQ: LSTA · IEX Real-Time Price · USD

3.550

0.00 (0.00%)

At close: Jul 19, 2024, 4:00 PM

3.440

-0.110 (-3.10%)

Pre-market: Jul 22, 2024, 8:25 AM EDT

Lisata Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1995
Net Income	-20.05	-20.84	-54.23	-27.47	-8.15	-19.36	Upgrade
Depreciation & Amortization	0.19	0.19	0.07	0.06	0.06	0.07	Upgrade
Share-Based Compensation	1.82	2.04	2.64	2.01	1.27	1.3	Upgrade
Other Operating Activities	-0.81	-1.42	30.35	3.16	-2	-0.88	Upgrade
Operating Cash Flow	-18.86	-20.03	-21.17	-22.25	-8.82	-18.88	Upgrade
Capital Expenditures	0	0	-0.29	-0.06	-0.02	0	Upgrade
Acquisitions	0	0	-3.32	0	0	0	Upgrade
Change in Investments	12.35	10.1	32.52	-54.84	-7.26	21.43	Upgrade
Other Investing Activities	-0.1	-	-	-	-	-	Upgrade
Investing Cash Flow	12.25	10.1	28.91	-54.9	-7.28	21.43	Upgrade
Share Issuance / Repurchase	0.48	0.48	0.04	85.52	18.73	1.31	Upgrade
Other Financing Activities	-0.15	-0.09	-0.27	-0.25	-0.15	-0.13	Upgrade
Financing Cash Flow	0.33	0.39	-0.22	85.28	18.58	1.18	Upgrade
Exchange Rate Effect	-0.06	-0.02	-0.01	0	0	0	Upgrade
Net Cash Flow	-6.35	-9.56	7.51	8.14	2.48	3.73	Upgrade
Free Cash Flow	-18.86	-20.03	-21.46	-22.31	-8.84	-18.88	Upgrade
Free Cash Flow Per Share	-2.27	-2.48	-4.14	-6.05	-8.59	-27.43	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).